Conference "In vivo evaluation of calcium-responsive MRI probes"le Monday 16 March 2020 to 14h30
Dr Tanja Gambino from MPI for Biological Cybernetics (Tübingen, Germany) will give a conference at IBIO during her stay in Bordeaux.
In vivo evaluation of calcium-responsive MRI probes
For the purpose of monitoring pathophysiological processes, magnetic resonance imaging (MRI) is considered to be the one of the leading imaging techniques. However, much work must still be done in order to enable the detection and monitoring of the fundamental biomarkers. An approach using bioresponsive MRI probes has that potential. By alternating the MR image contrast these probes could report on specific biomarkers involved in biological processes of interest.
Calcium is an ideal target for such MRI probes, because it is one of the essential metals participating in numerous biological signaling pathways. Thus, we developed different methods to achieve quantification and tracking of calcium in vivo. Using a calcium-responsive MRI probe and a remote transient ischemic model, we established a novel technique that can be used for the early detection and monitoring of cerebral ischemia. Nonetheless, to achieve the absolute quantification of calcium, information about the local concentration of the bioresponsive probe is required. Here we worked in two directions. One approach utilised a fluorescence-labelled dendrimeric probe, where MRI was combined together with post-mortem fluorescence imaging. Alternatively, we employed a calcium-responsive MRI probe incorporated in a highly fluorinated lipid nanoparticle, where it was demonstrated that a single imaging modality could suffice.